These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 27074285)

  • 1. Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.
    Wagner JR; Lee CT; Durrant JD; Malmstrom RD; Feher VA; Amaro RE
    Chem Rev; 2016 Jun; 116(11):6370-90. PubMed ID: 27074285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
    Platania CBM; Bucolo C
    Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular dynamics ensemble-based approach for the mapping of druggable binding sites.
    Ivetac A; McCammon JA
    Methods Mol Biol; 2012; 819():3-12. PubMed ID: 22183526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding G Protein-Coupled Receptor Allostery via Molecular Dynamics Simulations: Implications for Drug Discovery.
    Basith S; Lee Y; Choi S
    Methods Mol Biol; 2018; 1762():455-472. PubMed ID: 29594786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric drugs and mutations: chances, challenges, and necessity.
    Guarnera E; Berezovsky IN
    Curr Opin Struct Biol; 2020 Jun; 62():149-157. PubMed ID: 32062398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.
    Sheik Amamuddy O; Veldman W; Manyumwa C; Khairallah A; Agajanian S; Oluyemi O; Verkhivker G; Tastan Bishop O
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
    An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
    J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markov models for the elucidation of allosteric regulation.
    Sengupta U; Strodel B
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1749):. PubMed ID: 29735732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric sites can be identified based on the residue-residue interaction energy difference.
    Ma X; Qi Y; Lai L
    Proteins; 2015 Aug; 83(8):1375-84. PubMed ID: 25185787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Computational Identification of Allosteric Sites and Pathways in Proteins.
    Daura X
    Adv Exp Med Biol; 2019; 1163():141-169. PubMed ID: 31707703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
    Lu S; Shen Q; Zhang J
    Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing allostery: a novel approach to drug discovery.
    Lu S; Li S; Zhang J
    Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Allosteric and Orthosteric Sites.
    Zhang W; Xie J; Lai L
    Adv Exp Med Biol; 2019; 1163():89-105. PubMed ID: 31707701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging computational approaches for the study of protein allostery.
    Collier G; Ortiz V
    Arch Biochem Biophys; 2013 Oct; 538(1):6-15. PubMed ID: 23933229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.